376 related articles for article (PubMed ID: 17310863)
1. Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Carley DW; Olopade C; Ruigt GS; Radulovacki M
Sleep; 2007 Jan; 30(1):35-41. PubMed ID: 17310863
[TBL] [Abstract][Full Text] [Related]
2. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea.
Marshall NS; Yee BJ; Desai AV; Buchanan PR; Wong KK; Crompton R; Melehan KL; Zack N; Rao SG; Gendreau RM; Kranzler J; Grunstein RR
Sleep; 2008 Jun; 31(6):824-31. PubMed ID: 18548827
[TBL] [Abstract][Full Text] [Related]
3. Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.
Prasad B; Radulovacki M; Olopade C; Herdegen JJ; Logan T; Carley DW
Sleep; 2010 Jul; 33(7):982-9. PubMed ID: 20614859
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.
Carley DW; Radulovacki M
Am J Respir Crit Care Med; 1999 Dec; 160(6):1824-9. PubMed ID: 10588592
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
6. Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.
Schmickl CN; Li Y; Orr JE; Jen R; Sands SA; Edwards BA; DeYoung P; Owens RL; Malhotra A
Chest; 2020 Aug; 158(2):765-775. PubMed ID: 32278781
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
8. Assessment of the test-retest reliability of laboratory polysomnography.
Levendowski DJ; Zack N; Rao S; Wong K; Gendreau M; Kranzler J; Zavora T; Westbrook PR
Sleep Breath; 2009 May; 13(2):163-7. PubMed ID: 18766393
[TBL] [Abstract][Full Text] [Related]
9. Drug therapy for obstructive sleep apnoea in adults.
Smith I; Lasserson TJ; Wright J
Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS).
Castillo JL; Menendez P; Segovia L; Guilleminault C
Sleep Med; 2004 Sep; 5(5):507-8. PubMed ID: 15341898
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms and obesity as predictors of sleepiness and quality of life in patients with REM-related obstructive sleep apnea: cross-sectional analysis of a large clinical population.
Pamidi S; Knutson KL; Ghods F; Mokhlesi B
Sleep Med; 2011 Oct; 12(9):827-31. PubMed ID: 21978724
[TBL] [Abstract][Full Text] [Related]
12. Obstructive sleep apnea related to rapid-eye-movement or non-rapid-eye-movement sleep: comparison of demographic, anthropometric, and polysomnographic features.
Sunnetcioglu A; Sertogullarından B; Ozbay B; Gunbatar H; Ekin S
J Bras Pneumol; 2016; 42(1):48-54. PubMed ID: 26982041
[TBL] [Abstract][Full Text] [Related]
13. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
14. Half of patients with obstructive sleep apnea have a higher NREM AHI than REM AHI.
Siddiqui F; Walters AS; Goldstein D; Lahey M; Desai H
Sleep Med; 2006 Apr; 7(3):281-5. PubMed ID: 16564214
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Antidepressants in the Treatment of Obstructive Sleep Apnea Compared to Placebo. A Systematic Review with Meta-Analyses.
AbdelFattah MR; Jung SW; Greenspan MA; Padilla M; Enciso R
Sleep Breath; 2020 Jun; 24(2):443-453. PubMed ID: 31720982
[TBL] [Abstract][Full Text] [Related]
16. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the polysomnographic features of obstructive sleep apnea.
O'Connor C; Thornley KS; Hanly PJ
Am J Respir Crit Care Med; 2000 May; 161(5):1465-72. PubMed ID: 10806140
[TBL] [Abstract][Full Text] [Related]
18. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
[TBL] [Abstract][Full Text] [Related]
19. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.
Aslan S; Isik E; Cosar B
Sleep; 2002 Sep; 25(6):677-9. PubMed ID: 12224847
[TBL] [Abstract][Full Text] [Related]
20. Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold.
Smales ET; Edwards BA; Deyoung PN; McSharry DG; Wellman A; Velasquez A; Owens R; Orr JE; Malhotra A
Ann Am Thorac Soc; 2015 May; 12(5):758-64. PubMed ID: 25719754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
